SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001851734-21-000062
Filing Date
2021-11-10
Accepted
2021-11-10 17:19:38
Documents
13
Period of Report
2021-11-09
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fwbi20211110_8k.htm   iXBRL 8-K 24713
  Complete submission text file 0001851734-21-000062.txt   164084

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20211109.xsd EX-101.SCH 3595
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fwbi-20211109_def.xml EX-101.DEF 12189
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20211109_lab.xml EX-101.LAB 16398
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20211109_pre.xml EX-101.PRE 12459
6 EXTRACTED XBRL INSTANCE DOCUMENT fwbi20211110_8k_htm.xml XML 2769
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 211397877
SIC: 2834 Pharmaceutical Preparations